Table 3:
The use of oncological treatments prior or after airway stenting and their associationa with survival
| n | HR (95% CI) | P-value | |
|---|---|---|---|
| Prior oncological treatment | |||
| None | 47 | 1 | – |
| Radiotherapy | 13 | 0.59 (0.29–1.17) | 0.13 |
| Chemoradiotherapy | 23 | 1.31 (0.79–2.19) | 0.29 |
| Chemotherapy | 18 | 1.10 (0.63–1.89) | 0.746 |
| Oncological treatment after stenting | |||
| None | 57 | 1 | – |
| Radiotherapy | 19 | 0.79 (0.47–1.34) | 0.38 |
| Chemoradiotherapy | 15 | 0.36 (0.19–0.66) | 0.001 |
| Chemotherapy | 3 | 0.54 (0.17–1.73) | 0.30 |
| No data | 7 | 0.76 (0.34–1.67) | 0.49 |
a
The associations between oncological treatments and overall survival were analysed using Cox proportional hazards model. HRs and 95% CIs are reported.
CI: confidence interval; HR: hazard ratio.